持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2023/10/06 | 日証協 | 135,607株 | +218.92% | 230,146株 | +120.42% | 196,944株 | +25.08% | 133,190株 | +49.71% |
2023/09/29 | 日証協 | 42,521株 | +50.68% | 104,414株 | +110.2% | 157,451株 | +3.64% | 88,967株 | -3.08% |
2023/09/22 | 日証協 | 28,220株 | +1.42% | 49,674株 | +44.97% | 151,925株 | +4.49% | 91,794株 | +74.65% |
2023/09/15 | 日証協 | 27,824株 | +69.43% | 34,266株 | +1293.49% | 145,391株 | -1.48% | 52,558株 | -11.74% |
2023/09/08 | 日証協 | 16,422株 | -27.2% | 2,459株 | -54.46% | 147,568株 | -3.99% | 59,548株 | -38.53% |
2023/09/01 | 日証協 | 22,559株 | -55.45% | 5,400株 | -94.52% | 153,700株 | -12.93% | 96,867株 | -9.71% |
2023/08/25 | 日証協 | 50,633株 | +15.24% | 98,581株 | +165.09% | 176,517株 | +17.98% | 107,281株 | +133.73% |
2023/08/18 | 日証協 | 43,938株 | +0.87% | 37,188株 | -38.89% | 149,617株 | +2.33% | 45,900株 | -6.89% |
2023/08/10 | 日証協 | 43,558株 | +6.87% | 60,857株 | -3.6% | 146,212株 | +4.35% | 49,295株 | -46.77% |
2023/08/04 | 日証協 | 40,758株 | -29.08% | 63,132株 | +88.77% | 140,117株 | -13.84% | 92,600株 | -5.9% |
2023/07/28 | 日証協 | 57,468株 | -31.76% | 33,444株 | -18.71% | 162,633株 | -8.59% | 98,409株 | +21.64% |
2023/07/21 | 日証協 | 84,209株 | -32.12% | 41,144株 | -76.39% | 177,924株 | -17.25% | 80,900株 | -7.44% |
2023/07/14 | 日証協 | 124,053株 | -1.7% | 174,229株 | +48.06% | 215,021株 | -0.21% | 87,400株 | +84.56% |
2023/07/07 | 日証協 | 126,201株 | -22.12% | 117,676株 | -35.71% | 215,467株 | -14.42% | 47,355株 | -58.64% |
2023/06/30 | 日証協 | 162,047株 | -6.08% | 183,041株 | -15.03% | 251,758株 | -2.71% | 114,500株 | -3.64% |
2023/06/23 | 日証協 | 172,531株 | +0.64% | 215,422株 | +17.79% | 258,781株 | +1.9% | 118,829株 | +5.46% |
2023/06/16 | 日証協 | 171,429株 | +3.72% | 182,885株 | -38.12% | 253,949株 | +2.9% | 112,674株 | +3.53% |
2023/06/09 | 日証協 | 165,279株 | +33.09% | 295,549株 | +130.62% | 246,785株 | +16.91% | 108,829株 | +111.73% |
2023/06/02 | 日証協 | 124,186株 | -15.45% | 128,155株 | -51.29% | 211,085株 | -7% | 51,400株 | +4.26% |
※株式分割は考慮していませんのでご注意ください。
Page Top